TW200502234A - Pyridyloxymethyl and benzisoxazole azabicyclic derivatives - Google Patents

Pyridyloxymethyl and benzisoxazole azabicyclic derivatives

Info

Publication number: TW200502234A
Authority: TW; Taiwan
Prior art keywords: pyridyloxymethyl; benzisoxazole; azabicyclic derivatives; disorders; benzisoxazole azabicyclic
Prior art date: 2003-03-12

Application number

TW093106481A

Other languages

English (en)

Inventor

Gene Michael Bright

Michael Aaron Brodney

Bishop Wlodecki

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-12

Filing date

2004-03-11

Publication date

2005-01-16

2004-03-11 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-01-16 Publication of TW200502234A publication Critical patent/TW200502234A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Cardiology (AREA)
Pregnancy & Childbirth (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

TW093106481A 2003-03-12 2004-03-11 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives TW200502234A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US45392503P	2003-03-12	2003-03-12

Publications (1)

Publication Number	Publication Date
TW200502234A true TW200502234A (en)	2005-01-16

Family

ID=32990837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093106481A TW200502234A (en)	2003-03-12	2004-03-11	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives

Country Status (31)

Country	Link
US (1)	US7345038B2 (zh)
EP (1)	EP1608648B1 (zh)
JP (2)	JP3910627B2 (zh)
KR (2)	KR20070074667A (zh)
CN (1)	CN100389115C (zh)
AP (1)	AP2005003390A0 (zh)
AR (1)	AR043537A1 (zh)
AU (2)	AU2004220327B2 (zh)
BR (1)	BRPI0408248A (zh)
CA (1)	CA2518740C (zh)
EA (1)	EA009527B1 (zh)
EC (1)	ECSP056011A (zh)
GT (1)	GT200400041A (zh)
HK (1)	HK1085725A1 (zh)
HR (1)	HRP20050798A2 (zh)
IL (1)	IL170290A (zh)
MA (1)	MA27747A1 (zh)
MX (1)	MXPA05009660A (zh)
NL (1)	NL1025710C2 (zh)
NO (1)	NO20054095L (zh)
OA (1)	OA13038A (zh)
PA (1)	PA8597501A1 (zh)
PE (1)	PE20041057A1 (zh)
PL (1)	PL378749A1 (zh)
RS (1)	RS20050692A (zh)
TN (1)	TNSN05224A1 (zh)
TW (1)	TW200502234A (zh)
UA (1)	UA78437C2 (zh)
UY (1)	UY28225A1 (zh)
WO (1)	WO2004081007A1 (zh)
ZA (1)	ZA200506373B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6994726B2 (en) *	2004-05-25	2006-02-07	Calcitec, Inc.	Dual function prosthetic bone implant and method for preparing the same
AR046337A1 (es) *	2003-10-15	2005-12-07	Osi Pharm Inc	Imidazopirazina inhibidoras de las tirosinquinasas
WO2005082370A1 (en) *	2004-01-29	2005-09-09	Pfizer Products Inc.	Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
EP2308879A1 (en) *	2004-04-02	2011-04-13	OSI Pharmaceuticals, Inc.	6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
MY139689A (en)	2004-07-20	2009-10-30	Osi Pharm Inc	Imidazotriazines as protein kinase inhibitors
CA2580042A1 (en) *	2004-09-10	2006-03-16	Pfizer Products Inc.	Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
US8575164B2 (en) *	2005-12-19	2013-11-05	OSI Pharmaceuticals, LLC	Combination cancer therapy
WO2009091939A1 (en) *	2008-01-18	2009-07-23	Osi Pharmaceuticals, Inc.	Imidazopyrazinol derivatives for the treatment of cancers
JP2011520970A (ja) *	2008-05-19	2011-07-21	オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド	置換されたイミダゾピラジン類およびイミダゾトリアジン類
JP2012524119A (ja)	2009-04-20	2012-10-11	オーエスアイ・ファーマシューティカルズ，エルエルシー	Ｃ−ピラジン−メチルアミンの調製
EP2427192A1 (en) *	2009-05-07	2012-03-14	OSI Pharmaceuticals, LLC	Use of osi-906 for treating adrenocortical carcinoma
JP2013540145A (ja) *	2010-10-21	2013-10-31	ウニベルシテートデスザールランデス	コルチゾール依存性疾患の治療用の選択的ｃｙｐ１１ｂ１阻害剤
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US9980945B2 (en)	2015-01-13	2018-05-29	Vanderbilt University	Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US9585867B2 (en)	2015-08-06	2017-03-07	Charles Everett Ankner	Cannabinod formulation for the sedation of a human or animal
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer
EP4429465A1 (en)	2021-11-10	2024-09-18	Symrise AG	Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990008148A1 (en) *	1989-01-23	1990-07-26	Pfizer Inc.	Bis-aza-bicyclic anxiolytic agents
US5167034A (en) *	1990-06-18	1992-11-24	International Business Machines Corporation	Data integrity for compaction devices
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5565453A (en) *	1991-09-25	1996-10-15	Pfizer Inc.	Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
ES2137986T3 (es) *	1992-06-16	2000-01-01	Pfizer	Procedimiento y productos intermedios para agentes ansioliticos bis-aza-biciclicos.
US5731307A (en) *	1994-09-30	1998-03-24	Pfizer, Inc.	Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
JP4447663B2 (ja)	1997-05-30	2010-04-07	ニューロサーチ、アクティーゼルスカブ	ニコチン性ａｃｈレセプターに於けるコリン作動性リガンドとしての８−アザビシクロ（３．２．１）オクト−２−エン及びオクタン誘導体
PA8469101A1 (es) *	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1
PT1114028E (pt)	1998-08-26	2007-02-28	Aventis Pharma Ltd	Aza-biciclos moduladores da inibição da adesão celular
CN1326457A (zh)	1998-09-18	2001-12-12	巴斯福股份公司	作为激酶抑制剂的4－氨基吡咯并嘧啶
SK3842001A3 (en)	1998-09-18	2002-04-04	Basf Ag	Pyrrolopyrimidines as protein kinase inhibitors (revised)
UA62015C2 (en) *	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
EE04799B1 (et)	1999-03-12	2007-04-16	Boehringer Ingelheim Pharmaceuticals, Inc.	Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
EP1177792A3 (en) *	2000-07-27	2002-10-23	Pfizer Products Inc.	Dopamine D4 Ligands for the treatment of novelty-seeking disorders

2004
- 2004-02-23 WO PCT/IB2004/000499 patent/WO2004081007A1/en active Application Filing
- 2004-02-23 KR KR1020077013527A patent/KR20070074667A/ko not_active Application Discontinuation
- 2004-02-23 BR BRPI0408248-6A patent/BRPI0408248A/pt not_active IP Right Cessation
- 2004-02-23 OA OA1200500259A patent/OA13038A/en unknown
- 2004-02-23 RS YUP-2005/0692A patent/RS20050692A/sr unknown
- 2004-02-23 EP EP04713592A patent/EP1608648B1/en not_active Expired - Lifetime
- 2004-02-23 AU AU2004220327A patent/AU2004220327B2/en not_active Ceased
- 2004-02-23 PL PL378749A patent/PL378749A1/pl not_active Application Discontinuation
- 2004-02-23 UA UAA200508639A patent/UA78437C2/uk unknown
- 2004-02-23 KR KR1020057016859A patent/KR100767854B1/ko not_active IP Right Cessation
- 2004-02-23 CA CA2518740A patent/CA2518740C/en not_active Expired - Fee Related
- 2004-02-23 JP JP2006506261A patent/JP3910627B2/ja not_active Expired - Fee Related
- 2004-02-23 AP AP2005003390A patent/AP2005003390A0/xx unknown
- 2004-02-23 EA EA200501148A patent/EA009527B1/ru not_active IP Right Cessation
- 2004-02-23 CN CNB2004800066516A patent/CN100389115C/zh not_active Expired - Fee Related
- 2004-02-23 MX MXPA05009660A patent/MXPA05009660A/es active IP Right Grant
- 2004-03-08 PA PA20048597501A patent/PA8597501A1/es unknown
- 2004-03-09 PE PE2004000256A patent/PE20041057A1/es not_active Application Discontinuation
- 2004-03-10 AR ARP040100770A patent/AR043537A1/es not_active Application Discontinuation
- 2004-03-11 TW TW093106481A patent/TW200502234A/zh unknown
- 2004-03-11 GT GT200400041A patent/GT200400041A/es unknown
- 2004-03-11 UY UY28225A patent/UY28225A1/es not_active Application Discontinuation
- 2004-03-12 NL NL1025710A patent/NL1025710C2/nl not_active IP Right Cessation
- 2004-03-12 US US10/800,328 patent/US7345038B2/en not_active Expired - Fee Related
2005
- 2005-08-10 ZA ZA200506373A patent/ZA200506373B/en unknown
- 2005-08-15 IL IL170290A patent/IL170290A/en not_active IP Right Cessation
- 2005-09-02 NO NO20054095A patent/NO20054095L/no unknown
- 2005-09-12 HR HR20050798A patent/HRP20050798A2/hr not_active Application Discontinuation
- 2005-09-12 EC EC2005006011A patent/ECSP056011A/es unknown
- 2005-09-12 TN TNP2005000224A patent/TNSN05224A1/fr unknown
- 2005-09-12 MA MA28495A patent/MA27747A1/fr unknown
2006
- 2006-05-16 HK HK06105638.1A patent/HK1085725A1/xx not_active IP Right Cessation
- 2006-10-26 JP JP2006291545A patent/JP2007051155A/ja active Pending
2010
- 2010-07-23 AU AU2010203303A patent/AU2010203303A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PA8597501A1 (es)	2005-05-24
GT200400041A (es)	2005-03-23
NO20054095L (no)	2005-09-26
NO20054095D0 (no)	2005-09-02
EA200501148A1 (ru)	2006-04-28
KR20070074667A (ko)	2007-07-12
HRP20050798A2 (en)	2006-02-28
MA27747A1 (fr)	2006-02-01
US7345038B2 (en)	2008-03-18
IL170290A (en)	2011-02-28
AU2010203303A1 (en)	2010-08-12
WO2004081007A1 (en)	2004-09-23
JP3910627B2 (ja)	2007-04-25
JP2007051155A (ja)	2007-03-01
OA13038A (en)	2006-11-10
CN1759116A (zh)	2006-04-12
EA009527B1 (ru)	2008-02-28
AU2004220327B2 (en)	2010-06-24
TNSN05224A1 (fr)	2007-06-11
ECSP056011A (es)	2006-01-27
HK1085725A1 (en)	2006-09-01
RS20050692A (en)	2007-11-15
AU2004220327A1 (en)	2004-09-23
AR043537A1 (es)	2005-08-03
EP1608648B1 (en)	2012-07-18
NL1025710C2 (nl)	2005-10-10
AP2005003390A0 (en)	2005-09-30
US20050026922A1 (en)	2005-02-03
CN100389115C (zh)	2008-05-21
JP2006519830A (ja)	2006-08-31
MXPA05009660A (es)	2005-10-20
CA2518740C (en)	2011-01-11
PE20041057A1 (es)	2005-01-22
NL1025710A1 (nl)	2004-09-14
ZA200506373B (en)	2006-10-25
UA78437C2 (en)	2007-03-15
EP1608648A1 (en)	2005-12-28
UY28225A1 (es)	2004-11-08
PL378749A1 (pl)	2006-05-15
BRPI0408248A (pt)	2006-03-01
KR20050113221A (ko)	2005-12-01
KR100767854B1 (ko)	2007-10-17
CA2518740A1 (en)	2004-09-23

Publication	Publication Date	Title
TW200502234A (en)	2005-01-16	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
AU2002213336A1 (en)	2002-04-29	Substituted heterocyclic compounds for treating multidrug resistance
WO2006086562A3 (en)	2007-03-22	Phenylazetidinone derivatives
TNSN06397A1 (en)	2008-02-22	Pyrazole derivatives, compositions containing such compounds and methods of use
MXPA05010496A (es)	2005-11-16	Moduladores alostericos positivos del receptor de acetilcolina nicotinico.
PL1654253T3 (pl)	2007-05-31	Podstawione pochodne 3-pirolidynoindolu
UA88463C2 (ru)	2009-10-26	Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
EP1551803B8 (en)	2006-12-13	Azabicyclo derivatives as muscarinic receptor antagonists
HK1077193A1 (en)	2006-02-10	Alpha-7 nicotinic receptor agonists and statins incombination
TW200510317A (en)	2005-03-16	Caspase inhibitors and uses thereof
BRPI0507250A (pt)	2007-06-26	combinações para tratar desordens do snc
AU2002232558A1 (en)	2002-06-24	Compounds, compositions and methods for treatment of parasitic infections
HK1078466A1 (en)	2006-03-17	Treatment of affective disorders by the combined action of a nicotinic ; receptor agonist and a monoaminergic substance
MXPA05007771A (es)	2005-09-30	Procedimientos de tratamiento del dolor articular o para mejorar el sueno usando un agonista/antagonista de estrogeno.
WO2007006732A8 (en)	2008-01-24	Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
WO2001087287A3 (en)	2002-05-16	Use of pyrazole derivatives for treating infertility
WO2004032908A3 (en)	2004-08-12	Method of inhibiting angiogenesis
WO2003101382A3 (en)	2004-07-29	Compounds useful in the treatment of anthrax and inhibiting lethal factor
NZ530587A (en)	2004-12-24	Diazacycloalkanes as oxytocin agonists
WO2005041904A3 (en)	2006-12-28	Inhibitors of coronavirus protease and methods of use thereof
AU2003214535A8 (en)	2004-11-01	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
DE60213802D1 (de)	2006-09-21	Cak inhibitoren und deren verwendungen
WO2004078180A3 (en)	2005-05-06	Naaladase inhibitors for treating opioid tolerance
MXPA05011677A (es)	2005-12-15	Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina.
AU2002231777A1 (en)	2002-08-19	Use of mglur5 antagonists for the treatment of pruritic conditions